as on October 21, 2025 at 10:42 pm IST
Day's Low
Day's High
2.61%
Downside
7.01%
Upside
52 Week's Low
52 Week's High
83.03%
Downside
10.11%
Upside
Check Atai Life Sciences Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.5B
EPS (TTM)
-0.5014
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.97%
PE Ratio (TTM)
-3.76
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-94.8M
Revenue (TTM)
2.3M
Profit Margin
0.00%
Return On Equity TTM
23264800.00%
Track how Atai Life Sciences Nv P/E has moved over time to understand its valuation trends.
Atai Life Sciences Nv in the last 5 years
Lowest (-23.76x)
June 30, 2021
Today (-3.76x)
October 21, 2025
Industry (-0.88x)
October 21, 2025
Highest (-1.43x)
December 31, 2024
Today’s Price to Earnings Ratio: -3.76x
Compare market cap, revenue, PE, and other key metrics of Atai Life Sciences Nv with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.5B | NA | -3.76 | 0.00% | |
BUY | $35.5B | 359.02% | -16.34 | -259.82% | |
BUY | $63.1B | 259.92% | -505.15 | -12.96% | |
BUY | $106.9B | 98.27% | 29.67 | 31.86% | |
BUY | $61.3B | 0.76% | 14.58 | 31.37% |
The Atai Life Sciences Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atai Life Sciences Nv investment value today
Current value as on today
₹5,15,641
Returns
₹4,15,641
(+415.64%)
Returns from Atai Life Sciences Nv Stock
₹4,10,833 (+410.83%)
Dollar Returns*
₹4,808 (+4.81%)
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Atai Life Sciences Nv. Average target price of $11.75
Get share price movements and forecasts by analysts on Atai Life Sciences Nv.
What analysts predicted
47.83%UPSIDE
Target Price
$11.75
Current Price
$6.13
Analyzed by
13 Analysts
Target
$11.75
Atai Life Sciences Nv target price $11.75, a slight upside of 47.83% compared to current price of $6.13. According to 13 analysts rating.
Investment in Atai Life Sciences Nv Shares on INDmoney has grown by 105.66% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:105.66% versus previous 30 day period
Search interest for Atai Life Sciences Nv Stock has increased by 83% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:83% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, ATAI stock has moved up by 7.0%
Best in 1 Year
In the last 1 year, ATAI has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 3 years, Insmed Incorporated has given 809.6% return, outperforming this stock by 685.1%
Profit Down
Netprofit is down for the last 2 quarters, -26.43M → -27.72M (in $), with an average decrease of 4.9% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 1.55M → 719.0K (in $), with an average decrease of 53.8% per quarter
Organisation | Atai Life Sciences Nv |
Headquarters | Prof. J.H. Bavincklaan 7, Amstelveen, Netherlands, 1183 AT |
Industry | Commercial Services |
CEO | Dr. Srinivas G. Rao M.D., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Anne Johnson | Chief Financial Officer |
Dr. Gerd G. Kochendoerfer Ph.D. | Chief Operating Officer |
Dr. Glenn Short Ph.D. | Chief Scientific Officer |
Mr. Ryan Barrett J.D. | General Counsel & Corporate Secretary |
Dr. Kevin Craig M.D. | Chief Medical Officer |
Mr. Christian Angermayer | Co-Founder & Chairman of the Supervisory Board |
Dr. Srinivas G. Rao M.D., Ph.D. | Co-Founder, CEO & Executive Director |
Atai Life Sciences Nv share price today is $6.13 as on . Atai Life Sciences Nv share today touched a day high of $6.56 and a low of $5.97.
Atai Life Sciences Nv share touched a 52 week high of $6.75 on and a 52 week low of $1.04 on . Atai Life Sciences Nv stock price today i.e. is trending at $6.13,which is 9.19% down from its 52 week high and 489.42% up from its 52 week low.
Atai Life Sciences Nv market capitalisation is $0.00T as on .
Indian investors can start investing in Atai Life Sciences Nv (ATAI) shares with as little as ₹87.965 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Atai Life Sciences Nv stock (as per the Rupee-Dollar exchange rate as on ).
Based on Atai Life Sciences Nv share’s latest price of $6.13 as on October 21, 2025 at 10:42 pm IST, you will get 1.6313 shares of Atai Life Sciences Nv. Learn more about
fractional shares .